POLG gene encodes the catalytic subunit of DNA polymerase gamma, essential for mitochondrial DNA (mtDNA) replication and repair. Mutations in POLG have been linked to a spectrum of clinical phenotypes, resulting in autosomal recessive or dominant mitochondrial diseases. These mutations have been associated with heterogeneous phenotypes, presenting with varying severity and at different ages of onset, ranging from the neonatal period to late adult life. We screened 13 patients for POLG mutations. All patients underwent a complete neurological examination, and in most of cases, muscle biopsy was performed. We detected 15 different variations in 13 unrelated Italian patients. Two mutations were novel and mapped in the pol domain (p.Thr989dup and p.Ala847Thr) of the enzyme. We also report new cases carrying controversial variations previously described as incompletely penetrant or a variant of unknown significance. Our study increases the range of clinical presentations associated with mutations in POLG gene, underlining some peculiar clinical features, such as PEO associated with corneal edema, and epilepsy, severe neuropathy with achalasia. The addition of two new substitutions, including the second report of an in-frame duplication, to the growing list of defects increases the value of POLG genetic diagnosis in a range of neurological presentations.
Mitochondrial diseases DNA polymerase gamma Genetics Clinical phenotypes
This is a preview of subscription content, log in to check access.
Research was supported in part by a grant from Regione Toscana and Ministry of Public Health to AF (project entitled “Risk and determinants of dementia in patients with mild cognitive impairment and brain subcortical vascular changes: a study of clinical, neuro-imaging and biological markers”).
Compliance with ethical standards
Conflict of interest
The authors have no conflict of interest to declare.
Scuderi C, Borgione E, Castello F, Lo Giudice M, Santa Paola S, Giambirtone M et al (2015) The in cis T251I and P587L POLG1 base changes: description of a new family and literature review. Neuromuscul Disord 25:333–339. doi:10.1016/j.nmd.2015.01.004CrossRefPubMedGoogle Scholar
Horvath R, Hudson G, Ferrari G, Fütterer N, Ahola S, Lamantea E et al (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129:1674–1684. doi:10.1093/brain/awl088CrossRefPubMedGoogle Scholar
Hopkins SE, Somoza A, Gilbert DL (2010) Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease. J Child Neurol 25:752–756. doi:10.1177/0883073809343313CrossRefPubMedGoogle Scholar
Van Goethem G, Löfgren A, Dermaut B, Ceuterick C, Martin JJ, Van Broeckhoven C (2003) Digenic progressive external ophthalmoplegia in a sporadic patient: recessive mutations in POLG and C10orf2/Twinkle. Hum Mutat 22:175–176. doi:10.1002/humu.10246CrossRefPubMedGoogle Scholar
Luoma PT, Luo N, Löscher WN, Farr CL, Horvath R, Wanschitz J et al (2005) Functional defects due to spacer-region mutations of human mitochondrial DNA polymerase in a family with an ataxia-myopathy syndrome. Hum Mol Genet 14:1907–1920. doi:10.1093/hmg/ddi196CrossRefPubMedGoogle Scholar
Bortot B, Barbi E, Biffi S, Lunazzi G, Busani R, Burlina A et al (2009) Two novel POLG mutations causing hepatic mitochondrial DNA depletion with recurrent hypoketotic hypoglycaemia and fatal liver dysfunction. Dig Liver Dis 41:494–499. doi:10.1016/j.dld.2008.11.013CrossRefPubMedGoogle Scholar